00 | start with the evidence
CJC-1295 is a man-made peptide, built from small protein parts and tested in 2006.
The long-lasting form remained in blood near day 8. The shorter form lasted about 30 minutes. This page explains those findings.
What have small studies found about CJC-1295?
CJC-1295 is a chain of 30 amino acids, the small building blocks proteins are made of. Chemists swapped four of them, numbers 2, 8, 15, and 27, so your body is slower to break it down. One form also carries a small hook that latches onto albumin, a protein common in everyone's blood. Half of that hooked form had left the blood after 5.8-8.1 days; each dose group had its own average, all inside that span [1]. ConjuChem Biotechnologies developed it, and Teichman's team reported the human work in 2006 [1].
The main human study was small: healthy 21- to 61-year-old adults, each given one shot just under the skin. Doses were 30, 60, 125, and 250 micrograms, counted per kilogram the person weighed. Micrograms are tiny; it takes a million of them to make one gram. On average, growth hormone went up 2- to 10-fold, two to ten times its usual level, for at least six days. IGF-1, a hormone your liver makes whenever growth hormone climbs, went up 1.5- to 3-fold and stayed up nine to eleven days [1]. After repeat shots, IGF-1 sat above where it started for as long as 28 days [1]. There's no Phase 3 study, the large, late trial that has to confirm a drug helps and show its common harms. FDA hasn't approved any CJC-1295 drug [13]. World sport's drug-rules body bans it for athletes [10].
These are blood-test results. They don't show anyone got healthier. You can read what a CJC-1295 shot does in the body, which CJC-1295 dosage amounts were studied, and which CJC-1295 side effects people reported. A sales page leads with the promise. We lead with the limits.
What does CJC-1295 ask the growth gland for?
Your brain has its own way of asking for growth hormone. It sends a small protein down to the pituitary, a pea-sized gland just below the brain that makes growth hormone. Only the front end of that protein does the asking: its first 29 building blocks. A drug called sermorelin is a copy of just that front end, unchanged. Half of sermorelin leaves the blood in about 11-12 minutes [7]. CJC-1295 is the same short copy with four blocks swapped, and one form adds a hook gripping a blood protein [1][6].
A sales page may make this sound like a brand-new body process. It isn't. CJC-1295 works through the same route your body already uses [4]. Once growth hormone rises, the liver makes IGF-1, a second hormone, in answer. What CJC-1295 changes is timing. The swaps make it harder to break down, and the hook lets it ride along with a blood protein. It sends the same request to the same gland; it just keeps asking longer [1][6]. That limit is worth knowing before anyone tells you it does something new.
Did the studies make anyone healthier?
No. The one human CJC-1295 study moved blood-test numbers, and that's all it measured. After one long-lasting CJC-1295 shot, growth hormone ran 2- to 10-fold above normal across six days. IGF-1, the hormone the liver makes in answer, rose 1.5- to 3-fold over nine to eleven days [1]. A mouse study gets quoted too. Those mice were born missing a gene they need to grow normally. Daily shots started at one week old, and within five weeks the mice caught up to normal weight and length. Shots spaced further apart did less [3]. In the growth gland itself, cells had geared up to make more growth hormone [3].
A 2009 paper found many blood proteins shifted after adults got a shot [5]. The shifts fit higher IGF-1, but the paper didn't show anyone was better off. A 2017 study found higher IGF-1 in men who were also taking testosterone and other drugs [11]. The peptide hasn't passed a Phase 3 trial for any illness, or a fair trial on fat or muscle. Tesamorelin, a different drug, has better proof. Its trials were in people with HIV-associated fat build-up deep in the belly, and that fat fell by an average 15-18% [9]. That finding is tesamorelin's alone; it isn't evidence for CJC-1295.
What clinics say about CJC-1295 with ipamorelin comes from their own patients' accounts, not a controlled trial. Nobody has run a CJC-1295 trial with treated and untreated groups to check whether the pair helps.
What is CJC-1295 made from?
It is a man-made peptide built from amino acids, small building blocks used in proteins. The peptide copies a brain message that calls for growth hormone. Four altered parts make breakdown slower. One form also has a hook that joins a plentiful protein in your blood. ConjuChem Biotechnologies first described the compound in the mid-2000s. Teichman's team tested it in healthy adults in 2006 [1]. That's the useful short answer.
Which blood tests changed after CJC-1295?
The peptide prompts the growth gland, and growth hormone comes out into the blood in bursts [4]. In Teichman's 2006 study, one shot of long-lasting CJC-1295 raised growth hormone 2- to 10-fold on average, for at least six days. IGF-1, the liver's answering hormone, rose 1.5- to 3-fold and held nine to eleven days [1]. The hook kept the peptide stuck to a blood protein, which is why it lingered. None of that shows your health would improve.